Annual Working Capital
$173.93 M
+$87.37 M+100.95%
December 31, 2024
Summary
- As of March 3, 2025, PRME annual working capital is $173.93 million, with the most recent change of +$87.37 million (+100.95%) on December 31, 2024.
- During the last 3 years, PRME annual working capital has fallen by -$38.67 million (-18.19%).
- PRME annual working capital is now -35.56% below its all-time high of $269.90 million, reached on December 31, 2022.
Performance
PRME Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$173.93 M
-$34.27 M-16.46%
December 31, 2024
Summary
- As of March 3, 2025, PRME quarterly working capital is $173.93 million, with the most recent change of -$34.27 million (-16.46%) on December 31, 2024.
- Over the past year, PRME quarterly working capital has dropped by -$19.29 million (-9.98%).
- PRME quarterly working capital is now -18.19% below its all-time high of $212.60 million, reached on December 31, 2021.
Performance
PRME Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PRME Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +101.0% | -10.0% |
| 3 y3 years | -18.2% | -10.0% |
| 5 y5 years | +412.1% | -10.0% |
PRME Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.6% | +101.0% | -18.2% | +101.0% |
| 5 y | 5-year | -35.6% | +412.1% | -18.2% | +101.0% |
| alltime | all time | -35.6% | +412.1% | -18.2% | +101.0% |
Prime Medicine Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $173.93 M(+100.9%) | $173.93 M(-16.5%) |
| Sep 2024 | - | $208.19 M(+38.7%) |
| Jun 2024 | - | $150.05 M(-22.3%) |
| Mar 2024 | - | $193.21 M(+123.2%) |
| Dec 2023 | $86.55 M(-67.9%) | $86.55 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $269.90 M(+27.0%) | - |
| Sep 2022 | - | $126.63 M(-19.7%) |
| Jun 2022 | - | $157.77 M(-25.8%) |
| Dec 2021 | $212.60 M(+526.0%) | $212.60 M |
| Dec 2020 | $33.96 M | - |
FAQ
- What is Prime Medicine annual working capital?
- What is the all time high annual working capital for Prime Medicine?
- What is Prime Medicine annual working capital year-on-year change?
- What is Prime Medicine quarterly working capital?
- What is the all time high quarterly working capital for Prime Medicine?
- What is Prime Medicine quarterly working capital year-on-year change?
What is Prime Medicine annual working capital?
The current annual working capital of PRME is $173.93 M
What is the all time high annual working capital for Prime Medicine?
Prime Medicine all-time high annual working capital is $269.90 M
What is Prime Medicine annual working capital year-on-year change?
Over the past year, PRME annual working capital has changed by +$87.37 M (+100.95%)
What is Prime Medicine quarterly working capital?
The current quarterly working capital of PRME is $173.93 M
What is the all time high quarterly working capital for Prime Medicine?
Prime Medicine all-time high quarterly working capital is $212.60 M
What is Prime Medicine quarterly working capital year-on-year change?
Over the past year, PRME quarterly working capital has changed by -$19.29 M (-9.98%)